Olson Tiffany's Form 4 filing
Castle Biosciences Inc (CSTL) · filed Jul 7, 2022
- Accession no.
- 0001447362-22-000121
- Filed
- Jul 7, 2022
- Trade date
- May 12, 2022
- Filing delay
- 56 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market purchases total $24.8K. It was filed 56 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Olson TiffanyCIK 0001442172 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 12, 2022 | Common Stock | PPurchaseAcquired | +1,100 | $18.76 | +$20,636 | 1,586 | Direct | |
| May 12, 2022 | Common Stock | PPurchaseAcquired | +220 | $18.77 | +$4,129.4 | 1,806 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.